Da Hee Han

PharmD

Most Recent Articles by Da Hee Han

Treatment for Alzheimer-Related Agitation Gets Fast Track Status

Treatment for Alzheimer-Related Agitation Gets Fast Track Status

By

Currently, there are no approved treatments for behavioral symptoms in Alzheimer disease.

Drug Used for Reversal of Neuromuscular Block Recalled Due to Mislabeling

Drug Used for Reversal of Neuromuscular Block Recalled Due to Mislabeling

By

Neostigmine Methylsulfate Injection, a cholinesterase inhibitor, is indicated to reverse the effects of non-depolarizing neuromuscular blockers after surgery.

Rivaroxaban Use in Older Patients: Does Age Influence Safety, Efficacy?

Rivaroxaban Use in Older Patients: Does Age Influence Safety, Efficacy?

By

Data from large Phase 3 studies showed that treatment with rivaroxaban was found to be safe and effective in older patients.

Menkes Disease Treatment Granted Fast Track Status by FDA

Menkes Disease Treatment Granted Fast Track Status by FDA

By

CUTX-101, a subcutaneous injectable formulation of copper histidinate, is designed to supplement blood and brain copper levels in patients with Menkes disease.

FDA Approves New Pimavanserin Formulation, Dosage Strength

FDA Approves New Pimavanserin Formulation, Dosage Strength

By

Nuplazid, a non-dopaminergic, selective serotonin inverse agonist, targets 5-HT2A receptors that are thought to be involved in Parkinson's disease psychosis.

More Articles by Da Hee Han

Sign Up for Free e-newsletters



CME Focus